Johns Hopkins ABX Guide
Tigecycline
INDICATIONS
FDA
FDA
- Complicated skin and skin structure infections (including those caused by MRSA and vancomycin-susceptible E. faecalis).
- Author’s comment: avoid in severe infections +/- bacteremia.
- Complicated intra-abdominal infections (as a single agent).
- Author’s comment: avoid in severe infections +/- bacteremia.
- Community-acquired bacterial pneumonia caused by S. pneumoniae (PCN-susceptible isolates), H. influenzae (beta-lactamase negative isolates), and Legionella pneumophila.
- Author’s comment: not a first-line agent and generally not used for CAP.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 4, 2018
Citation
Dzintars, Kathryn. "Tigecycline." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540549/all/Tigecycline.
Dzintars K. Tigecycline. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540549/all/Tigecycline. Accessed November 13, 2024.
Dzintars, K. (2018). Tigecycline. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540549/all/Tigecycline
Dzintars K. Tigecycline [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2024 November 13]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540549/all/Tigecycline.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tigecycline
ID - 540549
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2018/12/04/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540549/all/Tigecycline
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
